---
title: Buy Sitagliptin 50mg, 100mg Pills Online
description: Sitagliptin 50mg/100mg Pills is a trusted treatment for managing high blood sugar in type 2 diabetes. Order from our secure online pharmacy today.
type: product
language: en 
url: https://medsforsale.net/buy-sitagliptin-online-en
availability: in_stock
price_min: 44.99
price_max: 359.99
currency: USD
offers:
  - name: 50mg x 10 pills
    price: 44.99
  - name: 50mg x 20 pills
    price: 85.99
  - name: 50mg x 30 pills
    price: 125.99
  - name: 50mg x 40 pills
    price: 159.99
  - name: 50mg x 60 pills
    price: 221.99
  - name: 50mg x 90 pills
    price: 321.99
  - name: 100mg x 10 pills
    price: 49.99
  - name: 100mg x 20 pills
    price: 94.99
  - name: 100mg x 30 pills
    price: 134.99
  - name: 100mg x 40 pills
    price: 172.99
  - name: 100mg x 60 pills
    price: 248.99
  - name: 100mg x 90 pills
    price: 359.99
---

# Buy Sitagliptin 50mg, 100mg Pills Online

Sitagliptin is an oral diabetes medication that helps control blood sugar levels by regulating the levels of insulin your body produces after eating. Originally developed by Merck & Co. as Januvia, this medication is intended for adults with type 2 diabetes to improve glycemic control. It works effectively when combined with a proper diet and exercise program. Our pharmacy provides a reliable way to purchase Sitagliptin in 50mg and 100mg pills.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **50mg** | 10 pills | **$44.99** | $4.50 | In Stock |
| **50mg** | 20 pills | **$85.99** | $4.30 | In Stock |
| **50mg** | 30 pills | **$125.99** | $4.20 | In Stock |
| **50mg** | 40 pills | **$159.99** | $4.00 | In Stock |
| **50mg** | 60 pills | **$221.99** | $3.70 | In Stock |
| **50mg** | 90 pills | **$321.99** | $3.58 | In Stock |
| **100mg** | 10 pills | **$49.99** | $5.00 | In Stock |
| **100mg** | 20 pills | **$94.99** | $4.75 | In Stock |
| **100mg** | 30 pills | **$134.99** | $4.50 | In Stock |
| **100mg** | 40 pills | **$172.99** | $4.32 | In Stock |
| **100mg** | 60 pills | **$248.99** | $4.15 | In Stock |
| **100mg** | 90 pills | **$359.99** | $4.00 | In Stock |


[Buy Now](https://medsforsale.net/buy-sitagliptin-online-en)

## Introduction 

Sitagliptin, supplied as the active compound Sitagliptin phosphate, is an oral medication indicated for the management of type 2 diabetes mellitus. It is available in 50 mg and 100 mg tablet strengths and belongs to the dipeptidyl-peptidase-4 (DPP-4) inhibitor class. The drug lowers blood glucose by enhancing the body’s own incretin hormones, which increase insulin secretion and suppress glucagon release after meals. Sitagliptin is also examined in clinical research for several secondary and off-label applications, although these uses have not received formal regulatory approval.

## What is Sitagliptin? 

Sitagliptin is the generic version of well-known medications, containing the active compound Sitagliptin phosphate. [our online pharmacy](https://medsforsale.net/buy-sitagliptin-online-en) provides this generic alternative as a cost-effective treatment option. The drug was originally developed by Merck & Co. and received FDA approval in 2006 for type 2 diabetes. Commercially, it is marketed under brand names such as **Januvia** and **Janumet** (the latter combines sitagliptin with metformin). As a DPP-4 inhibitor, sitagliptin acts on a specific enzyme pathway that influences glucose homeostasis without directly stimulating insulin release.

## How Sitagliptin Works 

Sitagliptin binds selectively to the DPP-4 enzyme, preventing the rapid degradation of the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Elevated levels of GLP-1 and GIP prolong their action after a meal, leading to:

* Increased insulin secretion from pancreatic β-cells in a glucose-dependent manner. 
* Reduced glucagon release from α-cells, decreasing hepatic glucose production. 

Because its effect is glucose-dependent, the risk of hypoglycaemia is low when sitagliptin is used alone. The drug reaches peak plasma concentrations within 1-4 hours, shows a half-life of roughly 12 hours, and is eliminated mainly unchanged in the urine.

## Conditions Treated with Sitagliptin 

* **Type 2 Diabetes Mellitus (T2DM).** Sitagliptin is approved as monotherapy or in combination with other oral antihyperglycaemic agents (e.g., metformin, sulfonylureas) to improve glycaemic control in adults. Clinical trials have demonstrated reductions in HbA1c of .5-.9 percentage points over 24 weeks. 
* **Adjunct to Insulin Therapy.** In patients already receiving basal or basal-bolus insulin, sitagliptin can be added to lower post-prandial glucose excursions, allowing for modest insulin dose adjustments. 

The drug is not approved for type 1 diabetes, diabetic ketoacidosis, or gestational diabetes.

## Off-Label and Investigational Uses of Sitagliptin 

* **Prediabetes and Impaired Glucose Tolerance.** Small randomized studies have explored sitagliptin for delaying progression to overt T2DM, showing modest improvements in fasting glucose and HbA1c. This indication remains off-label and should be pursued only under specialist supervision. 
* **Non-Alcoholic Fatty Liver Disease (NAFLD).** Early-phase trials suggest that DPP-4 inhibition may reduce hepatic inflammation and steatosis, but conclusive evidence is lacking. 
* **Cardiovascular Risk Modulation.** Post-marketing analyses have examined sitagliptin’s impact on major adverse cardiovascular events (MACE). While the drug met non-inferiority criteria for safety, efficacy for cardiovascular protection is not established. 

All off-label applications lack regulatory endorsement. Patients should discuss potential benefits and risks with a qualified healthcare provider before use.

## Is Sitagliptin the Right Medication for You? 

Sitagliptin is most appropriate for adults with documented type 2 diabetes who have:

* Inadequate glycaemic control on diet and exercise alone. 
* A need for an oral agent with a low hypoglycaemia risk, especially when renal function is mildly reduced (eGFR ≥ 30 mL/min/1.73 m²). 

It is less suitable for individuals with:

* Severe renal impairment (eGFR < 30 mL/min/1.73 m²) without dose adjustment. 
* A history of pancreatitis, as DPP-4 inhibitors carry a precautionary label. 
* Known hypersensitivity to sitagliptin phosphate or any tablet excipients. 

Physicians often consider sitagliptin when patients cannot tolerate metformin or sulfonylureas, or when weight neutrality is a priority.

## Risks, Side Effects, and Interactions 

### Common 

- Upper respiratory tract infection (sore throat, nasal congestion) 
- Headache 
- Nasopharyngitis 
- Gastrointestinal discomfort (nausea, abdominal pain) 
- Mild skin rash 

These events are generally self-limiting and do not require discontinuation.

### Rare 

- Acute pancreatitis (severe abdominal pain radiating to the back) 
- Severe allergic reactions (angio-edema, urticaria, anaphylaxis) 
- Joint pain (arthralgia) 

Patients should seek medical evaluation promptly if any rare symptom develops.

### Serious 

- **Pancreatitis** - requires immediate emergency care. 
- **Severe hypersensitivity** - may involve respiratory compromise or cardiovascular collapse. 
- **Hypersensitivity-induced hepatic injury** - marked elevations in liver enzymes or jaundice. 

Although rare, these serious events merit urgent medical attention.

#### Drug-Drug Interactions 

- **Insulin and sulfonylureas** - combined use may increase hypoglycaemia risk; dose adjustments often necessary. 
- **Cyclosporine** - may raise sitagliptin plasma concentrations; monitor renal function. 
- **Rifampin** - can lower sitagliptin levels, potentially reducing efficacy. 

#### Drug-Food Interactions 

Sitagliptin can be taken with or without food; no specific dietary restrictions are required. However, excessive alcohol intake may exacerbate hypoglycaemia when combined with insulin or sulfonylureas.

## Use: Dosing, Missed Dose, Overdose 

* **Standard dosing** - 100 mg once daily for most adults with normal renal function. For eGFR 30-49 mL/min/1.73 m², the recommended dose is 50 mg once daily. 
* **Missed dose** - Take the missed tablet as soon as remembered, unless it is close to the time of the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule; do not double-dose. 
* **Overdose** - Acute overdose of sitagliptin is unlikely to be fatal but may cause symptomatic hypoglycaemia when combined with insulin or sulfonylureas. Seek emergency medical care; supportive measures include monitoring blood glucose and administering glucose if needed. 

### Practical Precautions 

- Swallow tablets whole with water; crushing or chewing may affect absorption. 
- Alcohol does not directly interact with sitagliptin but can amplify the hypoglycaemic effect of concomitant insulin. 
- Caution when operating heavy machinery until you know how sitagliptin affects you, especially during the first weeks of therapy. 

## FAQ 

- **Can I travel internationally with sitagliptin?** 
 Yes. Carry the medication in its original packaging with the prescription label (if applicable) and keep it in your carry-on luggage to avoid temperature extremes. 

- **What does a sitagliptin tablet look like?** 
 The generic 50 mg tablet is usually white, round, and film-coated; the 100 mg tablet may be white to off-white, biconvex, and also film-coated. Exact appearance can vary by manufacturer. 

- **Are there any inactive ingredients I should be aware of?** 
 Common excipients include microcrystalline cellulose, magnesium stearate, and hypromellose. If you have known allergies to these substances, verify the specific formulation before use. 

- **Is sitagliptin safe for patients with moderate kidney disease?** 
 Patients with an eGFR of 30-49 mL/min/1.73 m² should use the reduced 50 mg dose. Those with eGFR < 30 mL/min/1.73 m² are generally advised against using sitagliptin unless a specialist recommends a specific dosing strategy. 

- **Will sitagliptin appear on a standard drug test?** 
 Sitagliptin is not part of typical occupational or forensic drug-screen panels, so routine testing will not detect it. 

- **Can I store sitagliptin in a humid climate?** 
 Tablets should be kept in a dry place below 30 °C (86 °F). If you live in a high-humidity region, store the medication in a sealed container with a desiccant packet to maintain potency. 

- **How does sitagliptin compare to older diabetes drugs like sulfonylureas?** 
 Unlike sulfonylureas, sitagliptin has a low intrinsic risk of hypoglycaemia because its insulin-stimulating effect is glucose-dependent. It is also weight-neutral, whereas sulfonylureas can cause modest weight gain. 

- **What was the key clinical trial that supported sitagliptin’s approval?** 
 The pivotal Phase III studies (e.g., the “SITAGLIP-1” trial) demonstrated that sitagliptin 100 mg reduced HbA1c by an average of .6 % compared with placebo over 24 weeks, with a favorable safety profile. 

- **Is sitagliptin affected by grapefruit juice?** 
 Current evidence indicates that grapefruit juice does not significantly alter sitagliptin metabolism, so moderate consumption is unlikely to impact drug levels. 

- **Can I switch from a brand-name product to generic sitagliptin without dose changes?** 
 Yes. Generic sitagliptin phosphate is bioequivalent to the branded formulations, allowing a direct substitution at the same dosage strength. 

## Glossary 

**Dipeptidyl-Peptidase-4 (DPP-4) Inhibitor** 
: A class of oral antihyperglycaemic agents that block the DPP-4 enzyme, prolonging the activity of incretin hormones which regulate insulin and glucagon secretion. 

**HbA1c** 
: Hemoglobin-A1c, a laboratory measure reflecting average blood glucose levels over the previous 8-12 weeks; used to assess long-term diabetes control. 

**eGFR (Estimated Glomerular Filtration Rate)** 
: A calculation of kidney function based on serum creatinine, age, sex, and race; guides dosing adjustments for renally excreted drugs. 

**Incretin** 
: Hormones (primarily GLP-1 and GIP) released from the gut after eating that stimulate insulin release and suppress glucagon. 

## Buying Sitagliptin from [our online pharmacy](https://medsforsale.net/buy-sitagliptin-online-en) 

Sitagliptin can be purchased from **[our online pharmacy](https://medsforsale.net/buy-sitagliptin-online-en)**, which specializes in providing verified generic medications at prices near the manufacturer’s cost. We source products exclusively from licensed, internationally recognized suppliers, ensuring each batch meets stringent quality standards. 

Customers benefit from:

* **Affordability** - Generic sitagliptin is offered at a fraction of brand-name pricing, reducing out-of-pocket expenses. 
* **Verified Quality** - All tablets are inspected for authenticity and potency before shipment. 
* **Discreet, Reliable Delivery** - Packages are sent in unmarked, tamper-evident envelopes, with typical delivery times of 7 days for express service or approximately 3 weeks for standard airmail. 
* **Privacy-First Service** - As a pharmacy broker, we partner with overseas licensed pharmacies, allowing us to maintain a confidential ordering process that protects your personal information. 

For patients who encounter limited local availability, insurance barriers, or high costs, our service offers a safe and convenient pathway to obtain sitagliptin.

## Disclaimer 

The information presented about **Sitagliptin** serves only as a general educational resource and does not replace professional medical advice. All therapeutic decisions-including those concerning off-label applications-should be taken under the guidance of a qualified healthcare provider. Readers are presumed to be responsible adults capable of making informed health choices. [our online pharmacy](https://medsforsale.net/buy-sitagliptin-online-en) provides access to **Sitagliptin** for individuals who may experience limited availability through conventional pharmacies, insurance-based programs, or who are seeking cost-effective generic alternatives. Always consult your physician before initiating, modifying, or stopping any medication.